Your browser is no longer supported. Please, upgrade your browser.
NUVA NuVasive, Inc. daily Stock Chart
NuVasive, Inc.
Index- P/E67.44 EPS (ttm)0.96 Insider Own0.60% Shs Outstand49.68M Perf Week2.05%
Market Cap3.22B Forward P/E31.16 EPS next Y2.08 Insider Trans-10.47% Shs Float49.50M Perf Month4.20%
Income51.30M PEG4.20 EPS next Q0.41 Inst Own- Short Float7.48% Perf Quarter19.20%
Sales867.10M P/S3.71 EPS this Y453.30% Inst Trans2.62% Short Ratio6.68 Perf Half Y55.57%
Book/sh14.02 P/B4.62 EPS next Y26.21% ROA3.00% Target Price70.92 Perf Year20.58%
Cash/sh6.38 P/C10.15 EPS next 5Y16.06% ROE6.20% 52W Range36.81 - 65.00 Perf YTD19.77%
Dividend- P/FCF50.23 EPS past 5Y-6.00% ROI8.50% 52W High-0.31% Beta0.86
Dividend %- Quick Ratio1.70 Sales past 5Y11.10% Gross Margin75.30% 52W Low76.04% ATR1.14
Employees1600 Current Ratio2.40 Sales Q/Q16.40% Oper. Margin16.40% RSI (14)65.34 Volatility2.11% 1.60%
OptionableYes Debt/Eq0.96 EPS Q/Q186.10% Profit Margin4.90% Rel Volume0.33 Prev Close64.81
ShortableYes LT Debt/Eq0.79 EarningsJul 26 AMC Payout0.00% Avg Volume554.58K Price64.80
Recom1.80 SMA202.63% SMA505.32% SMA20022.90% Volume38,638 Change-0.02%
Jul-27-16Reiterated Barclays Overweight $63 → $71
Jul-13-16Upgrade JP Morgan Neutral → Overweight $55 → $74
May-27-16Upgrade Barclays Equal Weight → Overweight $58 → $63
Dec-11-15Upgrade BofA/Merrill Underperform → Neutral
Oct-06-15Upgrade Canaccord Genuity Hold → Buy $52 → $58
Sep-14-15Initiated Morgan Stanley Equal-Weight $60
Jul-29-15Upgrade Northland Capital Market Perform → Outperform $68
Jul-29-15Reiterated Barclays Equal Weight $54 → $56
Jun-03-15Downgrade Goldman Buy → Neutral
May-14-15Initiated Northland Capital Market Perform $46
Apr-15-15Downgrade Canaccord Genuity Buy → Hold $54 → $49
Feb-25-15Reiterated Brean Capital Buy $53 → $55
Jan-13-15Reiterated WallachBeth Buy $49 → $55
Jan-08-15Upgrade RBC Capital Mkts Sector Perform → Outperform $45 → $56
Dec-04-14Reiterated Brean Capital Buy $44 → $53
Sep-30-14Upgrade Brean Capital Hold → Buy $44
May-21-14Downgrade Needham Buy → Hold
Apr-30-14Reiterated RBC Capital Mkts Sector Perform $35 → $39
Apr-30-14Reiterated Canaccord Genuity Buy $51 → $48
Jan-22-14Reiterated Canaccord Genuity Buy $34 → $51
Aug-30-16 08:38AM  BioTelemetry Gets CE Mark for Holter Monitoring Software
08:19AM  Luminex Poised on Pipeline Strength, System Sales Upbeat
07:51AM  Phibro Animal Health (PAHC) Q4 Earnings Top, Decline Y/Y
Aug-29-16 10:02AM  Medtronic on Track with Covidien Synergy, Buys HeartWare
Aug-24-16 08:57AM  BioTelemetry Forms Partnership with Bloomlife, Stock Down
Aug-22-16 09:21AM  Akers Biosciences OxiCheck Study Results Positive, Stock Up
Aug-17-16 10:30AM  Phibro (PAHC) Focuses on Growth Amid Pricing Pressure
10:27AM  Zimmer Biomet Acquires CD Diagnostics, Targets PJI Market
Aug-12-16 09:16AM  Akers Biosciences (AKER) Q2 Loss Narrows Y/Y, Stock Gains
Aug-11-16 08:08AM  Alere (ALR) Reader Attains CE Mark, Submits Delayed 10K
Aug-04-16 03:08PM  ETFs with exposure to NuVasive, Inc. : August 4, 2016
01:05PM  Open house for Dayton-area company hiring 200 at
07:00AM  NuVasive Secures CMS Add-On Payment for Innovative MAGEC System Marketwired
Aug-03-16 12:45PM  NuVasive, Inc. :NUVA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016
11:40AM  These 4 Medical Technology Stocks Really Stand Out
Aug-02-16 04:39PM  CVS Health (CVS) Tops Q2 Earnings, Lags on Revenue, View Up
04:36PM  Omnicell (OMCL) Tops Q2 Earnings & Revenues, Margins Drag
11:03AM  Looking for Healthcare Stocks? Consider These Four
08:10AM  Buy These 5 Profitable Stocks for Improving Your Returns
Aug-01-16 07:04AM  NUVASIVE INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws;
07:00AM  Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors Marketwired
Jul-30-16 01:04PM  NUVASIVE INC Financials
Jul-29-16 06:20PM  Where Will a Healthy Zimmer Biomet Turn Next for Acquisitions?
Jul-27-16 03:27PM  NuVasive (NUVA) Beats on Q2 Earnings, Raises FY16 View
02:59AM  Edited Transcript of NUVA earnings conference call or presentation 26-Jul-16 8:30pm GMT
Jul-26-16 04:51PM  NuVasive tops Street 2Q forecasts
04:30PM  NuVasive Inc Earnings Call scheduled for 4:30 pm ET today
04:08PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S
04:02PM  NuVasive Reports Second Quarter 2016 Financial Results Marketwired
07:07AM  Q2 2016 NuVasive Inc Earnings Release - After Market Close
Jul-20-16 09:30AM featured highlights: Select Comfort, Select Medical Holdings, WEX, NuVasive and Post Holdings
Jul-19-16 12:55PM  ETFs with exposure to NuVasive, Inc. : July 19, 2016
09:41AM  5 Best Stocks with Upgraded Broker Ratings
Jul-18-16 05:08PM  NUVASIVE INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Jul-15-16 04:24PM  Alere Updates on 10K Filing, Reports Preliminary Q1 Figures
04:08PM  Will AmSurg's Merger with Envision Healthcare Drive Growth?
09:30AM  The Zacks Analyst Blog Highlights: NuVasive, Apogee Enterprises, Burlington Stores, Newfield Exploration and Saratoga Investment
07:22AM  Medtronic's IN.PACT Admiral DCB Wins FDA Nod for 150 mm
Jul-14-16 04:35PM  Buy 5 Momentum Picks That Brokers Love
Jul-13-16 02:30PM  Street Talk: Williams Co., Six Flags & more
08:30AM  Boston Scientific's Restructuring Plan & Innovation Offer Hope
06:23AM  NuVasive upgraded by JP Morgan
Jul-12-16 07:00AM  NuVasive to Feature Industry-Leading Portfolio at 23rd International Meeting on Advanced Spine Technologies Marketwired
Jul-11-16 09:28AM  Genomic Health to Offer Epic Science's AR-V7 test, Shares Up
Jul-07-16 09:00AM  Medical Device Consolidation Frenzy: Here's How to Play it
08:49AM  Cardiovascular Systems Seeks Device Approval in Japan
Jul-06-16 09:12AM  Zimmer Biomet Poised on LDR Inclusion, Product Launches
Jul-05-16 04:30PM  5 Medtech Stocks to Watch Out for in 2H16
09:03AM  NuVasive (NUVA) at 52-Week High on Strategic Initiatives
07:06AM  NUVASIVE INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statemen
07:00AM  NuVasive Completes Acquistion of Biotronic NeuroNetwork Marketwired
Jun-30-16 06:34PM  NuVasive settles spinal surgery patent fight with Medtronic Reuters
05:16PM  [$$] NuVasive to Settle Patent Dispute With Medtronic at The Wall Street Journal
04:12PM  NUVASIVE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:05PM  NuVasive Agrees to Settle Patent Litigation With Medtronic Marketwired
Jun-29-16 04:05PM  NuVasive Announces Conference Call and Webcast of Second Quarter 2016 Results Marketwired
01:06PM  4 Medical Device Makers With Healthy-Looking Charts
08:25AM  Medtronic Positive on HeartWare Buy, Covidien Synergies
Jun-24-16 07:00AM  Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine
Jun-22-16 08:26AM  Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
Jun-15-16 08:01AM  Boston Scientific: NICE Backs GreenLight XPS for BPH Cure
07:23AM  Bruker Well Poised on Product Innovation amid Currency Woes
Jun-10-16 09:25AM  Why NuVasive (NUVA) Could Beat Earnings Estimates Again
01:04AM  NuVasive Rises on High Trading Volumes
Jun-07-16 04:55PM  M&A Drives Up Spinal Stocks LDR, NuVasive, Globus Medical
12:57PM  Cramer Says Buy NuVasive on Heels of Zimmer's LDR Deal
11:07AM  Jim Cramer: Zimmer-LDR Deal Is Great at TheStreet
08:17AM  NuVasive to Strengthen Spine Service Line with Biotronic Buy
Jun-06-16 04:12PM  NUVASIVE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
04:05PM  NuVasive to Acquire Biotronic NeuroNetwork Marketwired
Jun-03-16 06:58PM  Cramers Exec Cut: Why you might hear about more cyber br...
11:02AM  NuVasive, Inc. :NUVA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016
10:55AM  Moving Average Crossover Alert: NuVasive (NUVA)
06:00AM  Jim Cramer's Top Takeaways: Ross Stores, TJX, Tesla, NXP Semiconductor, NuVasive
May-31-16 07:01AM  NuVasive Poised on Solid International Sales, Scope in Spine
07:00AM  NuVasive to Participate in Investor Events in June 2016 Marketwired
May-27-16 04:45PM  Palo Alto Draws Downgrades; Splunk Targets Hiked; NuVasive A Buy
09:43AM  NuVasive (NUVA) Stock Upgraded at Barclays
May-25-16 06:28AM  Abaxis (ABAX) Posts Solid Q4 amid International Headwind
May-24-16 11:07AM  IHIs Mid Caps on May 19: Medtronics Deal with Mazor Pressures Globus
May-23-16 07:00AM  NuVasive Launches Next Generation Biologics Technology Marketwired
May-20-16 05:08PM  NUVASIVE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-13-16 07:00AM  NuVasive to Feature Game-Changing, Integrated Spine Solutions at SpineWeek 2016 Marketwired
May-12-16 08:18AM  Boston Scientific (BSX): Q1 Earnings Beat amid CRM Woes Zacks
May-05-16 04:05PM  NuVasive to Participate in Investor Event in May 2016 Marketwired
Apr-28-16 07:00AM  NuVasive Extends Spine Innovator Leadership Position, Launches New Solutions at 84th AANS Annual Scientific Meeting Marketwired
Apr-27-16 12:03PM  NuVasive (NUVA) Tops Q1 Earnings, Grows Internationally +5.34%
02:03AM  Edited Transcript of NUVA earnings conference call or presentation 26-Apr-16 8:30pm GMT
Apr-26-16 05:45PM  NuVasive Rides Its Spinal Surgery Business Higher at Motley Fool
04:55PM  NuVasive reports 1Q loss AP
04:30PM  NuVasive Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:26PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S EDGAR Online
04:05PM  NuVasive Reports First Quarter 2016 Financial Results Marketwired
07:07AM  Q1 2016 NuVasive Inc Earnings Release - After Market Close CCBN
Apr-11-16 09:40AM  NuVasive: International Outlook Strong, Spine Prospects Bright
Apr-06-16 04:05PM  NuVasive Announces Conference Call and Webcast of First Quarter 2016 Results Marketwired
Apr-04-16 03:00AM  NuVasive Launches Integrated Global Alignment (iGA(TM)) Platform at BritSpine 2016 Marketwired
Mar-29-16 11:03AM  ETFs with exposure to NuVasive, Inc. : March 29, 2016
Mar-28-16 11:45AM  NuVasive, Inc. :NUVA-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-18-16 10:15AM  4 Well-Known Health Care Stocks Are Potential Buyout Candidates at 24/7 Wall St.
NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including biologics used for spinal fusion process. The company's principal product is Maximum Access Surgery (MAS), a minimally-disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, NVM5, and intraoperative monitoring (IMO) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. Its biologics products are used for spinal fusion or bone healing process, including Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; Propel DBM, a moldable demineralized bone matrix putty; and Osteocel Plus and Osteocel Pro, an allograft (donated human tissue) cellular matrix. The company's IMO services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. It also provides implants; and fixation products, including pedicle screws, rods, and plates. In addition, the company offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis (EOS), a spinal bracing and distraction system; and PRECICE, a limb lengthening system. NuVasive, Inc. sells its products to surgeons, hospitals, and other customer through independent sales agents, directly-employed sales forces, and distributors in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hannon JasonEVP, InternationalAug 23Option Exercise34.822,62591,40338,010Aug 24 06:42 PM
Hannon JasonEVP, InternationalAug 23Sale64.802,625170,10035,385Aug 24 06:42 PM
Hannon JasonEVP, InternationalAug 02Sale62.7011,184701,23735,385Aug 03 06:04 PM
HOWE LESLEY HDirectorAug 02Sale62.443,602224,90911,830Aug 03 06:05 PM
HOWE LESLEY HDirectorAug 01Option Exercise25.306,000151,80017,830Aug 03 06:05 PM
Leddy Peter MichaelEVP Global HRAug 01Option Exercise0.002,26505,337Aug 03 06:06 PM
Hannon JasonEVP, InternationalAug 01Option Exercise32.8048,5401,592,11283,925Aug 03 06:04 PM
Carol CoxEVP Ext Affairs & Corp MktgAug 01Option Exercise0.004,465010,241Aug 03 06:03 PM
Hannon JasonEVP, InternationalJul 20Option Exercise32.802,92095,77638,305Jul 22 06:01 PM
Hannon JasonEVP, InternationalJul 20Sale62.802,920183,37635,385Jul 22 06:01 PM
Blackford Quentin S.CFO and CAOJul 01Option Exercise0.003,125015,915Jul 05 06:03 PM
Hannon JasonEVP, InternationalJun 16Sale57.4212,303706,43835,385Jun 17 06:00 PM
Hannon JasonEVP, InternationalJun 15Option Exercise26.6250,0001,331,00085,385Jun 17 06:00 PM
Hannon JasonEVP, InternationalJun 15Sale58.422,231130,33547,688Jun 17 06:00 PM
BLAIR JACK RDirectorMay 19Option Exercise0.0011,892080,054May 23 06:00 PM
Miles PatrickPresident and COOMay 01Option Exercise0.005,600054,071May 03 06:08 PM
FARRELL PETER CDirectorFeb 18Option Exercise17.9014,000250,60021,627Feb 19 06:01 PM
BLAIR JACK RDirectorFeb 17Option Exercise18.3123,000421,15078,823Feb 18 06:00 PM
LUCIER GREGORY TChairman & CEOFeb 01Option Exercise0.0013,9980126,489Feb 03 06:19 PM
Miles PatrickPresident and COOFeb 01Option Exercise0.0033,653065,299Feb 03 06:20 PM
Link MatthewPresident, U.S. CommercialFeb 01Option Exercise0.0025,020088,015Feb 03 06:15 PM
Hannon JasonEVP, InternationalFeb 01Option Exercise0.0027,749046,314Feb 03 06:11 PM
Carol CoxEVP Ext Affairs & Corp MktgFeb 01Option Exercise0.001,92906,107Feb 03 06:09 PM
Blackford Quentin S.CFO and CAOFeb 01Option Exercise0.009,782015,959Feb 03 06:01 PM
Miles PatrickPresident and COOJan 06Sale54.0310,723579,34531,646Jan 07 04:11 PM
Miles PatrickPresident and COOJan 05Option Exercise38.9464,0282,493,25095,674Jan 07 04:11 PM
Miles PatrickPresident and COODec 16Sale52.569,127479,71531,646Dec 18 04:08 PM
Blackford Quentin S.CFO and CAODec 07Sale51.1015,000766,5002,599Dec 07 08:39 PM
Miles PatrickPresident and COODec 03Sale52.531,00052,53040,773Dec 03 05:33 PM
Miles PatrickPresident and COODec 02Option Exercise38.9485,9723,347,750113,726Dec 03 05:33 PM
Miles PatrickPresident and COODec 02Sale52.583,892204,64131,646Dec 03 05:33 PM
Miles PatrickPresident and COODec 01Sale52.1998151,19831,646Dec 03 05:33 PM
Miles PatrickPresident and COONov 02Sale48.1215,000721,80032,627Nov 04 04:11 PM
Link MatthewPresident, U.S. CommercialOct 05Sale50.721,71486,93453,089Oct 05 04:21 PM
Miles PatrickPresident and COOOct 01Sale48.1015,000721,50047,627Oct 05 04:12 PM
Powers RussellEVPSep 08Sale51.645,806299,82262,024Sep 10 04:12 PM
Hannon JasonEVP, Int'l and General CounselSep 02Sale51.971929,97818,565Sep 03 04:10 PM
Hannon JasonEVP, Int'l and General CounselSep 01Option Exercise38.9496,5083,758,022115,073Sep 03 04:10 PM
Hannon JasonEVP, Int'l and General CounselSep 01Sale52.0211,770612,27518,757Sep 03 04:10 PM
Miles PatrickPresident and COOSep 01Sale52.0315,000780,45062,627Sep 02 04:17 PM
Miles PatrickPresident and COOAug 31Option Exercise18.311392,54592,627Sep 02 04:17 PM
Miles PatrickPresident and COOAug 31Sale53.3415,000800,05477,627Sep 02 04:17 PM